Protalix BioTherapeutics, Inc. (PLX)
Biological Products, (No Diagnostic Substances)
Latest Price
$2.66
TTM P/E
11.08
Normalized P/E
--
Div Yield
--
Book Value
0.89
P/B Ratio
2.98
Institutional Ownership
18.4% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4.05M | $9.0M | 5.07% | +429.7K | 2026-06-30 |
| RENAISSANCE TECHNOLOGIES LLC | 1.10M | $2.0M | 1.37% | -128.8K | 2026-06-30 |
| STATE STREET CORP | 983.6K | $2.0M | 1.23% | +10.8K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 980.0K | $2.0M | 1.23% | +114.7K | 2026-06-30 |
| NORTHERN TRUST CORP | 922.3K | $2.0M | 1.15% | +36.9K | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 510.6K | $1.0M | 0.64% | +78.2K | 2026-06-30 |
| Stratos Wealth Partners, LTD. | 500.0K | $1.0M | 0.63% | -- | 2026-06-30 |
| DIMENSIONAL FUND ADVISORS LP | 493.4K | $1.0M | 0.62% | +196.6K | 2026-06-30 |
| GOLDMAN SACHS GROUP INC | 475.9K | $1.0M | 0.60% | +224.6K | 2026-06-30 |
| MARSHALL WACE, LLP | 452.8K | $1.0M | 0.57% | +433.7K | 2026-06-30 |